Literature DB >> 27902907

Thermal Stability Study of Five Newcastle Disease Attenuated Vaccine Strains.

Zineb Boumart1, Jihane Hamdi, Samira Daouam, Amal Elarkam, Khalid Omari Tadlaoui, Mehdi El Harrak.   

Abstract

Newcastle disease (ND) is a big concern throughout the world because of the devastating losses that can occur with commercial and backyard poultry. The major problem in many countries is the loss of the vaccine's effectiveness due to inadequate use or storage conditions, particularly in hot climates. In the present study, stability of the five, most-used NDV vaccine strains (I-2, LaSota, B1, Clone 30 [C30], and VG-GA) was tested comparatively at different storage temperatures (4 and 37 C for the freeze-dried form and 4, 24, 37, and 45 C for the freeze-dried vaccine reconstituted in diluents). The vaccine stability was evaluated by the cumulative infectious titer drop and the theoretical shelf life at particular temperatures. Results showed that I-2 and LaSota are the most stable vaccine strains compared to B1, C30, and VG-GA; they registered the lowest titer drops and the longest shelf life whether at cool, high, or room temperatures and for both freeze-dried and reconstituted vaccines.

Entities:  

Keywords:  Newcastle; infectious titer; poultry; stability; temperature; vaccine

Mesh:

Substances:

Year:  2016        PMID: 27902907     DOI: 10.1637/11426-042116-Reg.1

Source DB:  PubMed          Journal:  Avian Dis        ISSN: 0005-2086            Impact factor:   1.577


  4 in total

1.  Epidemiological surveillance of Newcastle disease virus in Egypt - a 6-year cohort study.

Authors:  Khaled G A Abozaid; Ahmed S Abdel-Moneim
Journal:  Trop Anim Health Prod       Date:  2022-08-01       Impact factor: 1.893

2.  Vaccine Quality Is a Key Factor to Determine Thermal Stability of Commercial Newcastle Disease (ND)Vaccines.

Authors:  Nabila Osman; Danny Goovaerts; Serageldeen Sultan; Jeremy Salt; Christian Grund
Journal:  Vaccines (Basel)       Date:  2021-04-09

3.  Intranasal vaccination of hamsters with a Newcastle disease virus vector expressing the S1 subunit protects animals against SARS-CoV-2 disease.

Authors:  Manolo Fernández Díaz; Katherine Calderón; Aldo Rojas-Neyra; Vikram N Vakharia; Ricardo Choque-Guevara; Angela Montalvan-Avalos; Astrid Poma-Acevedo; Dora Rios-Matos; Andres Agurto-Arteaga; Maria de Grecia Cauti-Mendoza; Norma Perez-Martinez; Gisela Isasi-Rivas; Luis Tataje-Lavanda; Yacory Sernaque-Aguilar; Freddy Ygnacio; Manuel Criollo-Orozco; Edison Huaccachi-Gonzalez; Elmer Delgado-Ccancce; Doris Villanueva-Pérez; Ricardo Montesinos-Millán; Kristel Gutiérrez-Manchay; Katherinne Pauyac-Antezana; Ingrid Ramirez-Ortiz; Stefany Quiñones-Garcia; Yudith Cauna-Orocollo; Katherine Vallejos-Sánchez; Angela Rios-Angulo; Dennis Núñez-Fernández; Mario I Salguedo-Bohorquez; Julio Ticona; Manolo Fernández-Sánchez; Eliana Icochea; Luis A Guevara-Sarmiento; Mirko Zimic
Journal:  Sci Rep       Date:  2022-06-20       Impact factor: 4.996

4.  Application of median lethal concentration (LC50) of pathogenic microorganisms and their antigens in vaccine development.

Authors:  Saganuwan Alhaji Saganuwan
Journal:  BMC Res Notes       Date:  2020-06-15
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.